IP Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

IP Group şirketinin toplam hissedar öz sermayesi £1.1B ve toplam borcu £152.0M olup, bu da borç-öz sermaye oranını 14.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £1.3B ve £214.7M dir.

Anahtar bilgiler

14.2%

Borç/özkaynak oranı

UK£152.00m

Borç

Faiz karşılama oranı	n/a
Nakit	UK£161.30m
Eşitlik	UK£1.07b
Toplam yükümlülükler	UK£214.70m
Toplam varlıklar	UK£1.29b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: IPOL 'nin kısa vadeli varlıkları ( £207.8M ) kısa vadeli yükümlülüklerini ( £22.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: IPOL şirketinin kısa vadeli varlıkları ( £207.8M ) uzun vadeli yükümlülüklerini ( £192.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: IPOL şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: IPOL şirketinin borç/öz sermaye oranı son 5 yılda 9.9% seviyesinden 14.2% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: IPOL şirketinin mevcut serbest nakit akışına göre 3 yıldan fazla bir süre için yeterli nakit pistine sahip olduğu belirtiliyor.

Tahmini Nakit Akışı: IPOL serbest nakit akışı her yıl % 10 oranında tarihsel oranda büyümeye devam ederse 3 yıldan fazla bir süre için yeterli nakit akışına sahip olur

IP Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

IP Group Plc to Report First Half, 2024 Results on Sep 17, 2024

Forcepoint LLC entered into a definitive agreement to acquire Garrison Technology Limited from IP Group Plc (LSE:IPO).

CEO & Executive Director recently sold UK£98k worth of stock

Full year 2023 earnings released: UK£0.17 loss per share (vs UK£0.33 loss in FY 2022)

Full year 2023 earnings released: UK£0.17 loss per share (vs UK£0.33 loss in FY 2022)

IP Group Plc, Annual General Meeting, Jun 12, 2024

New minor risk - Financial data availability

IP Group Plc to Report Fiscal Year 2023 Results on Mar 13, 2024

IP Group Plc (LSE:IPO) commences an Equity Buyback Plan for 103,677,065 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2023.

First half 2023 earnings released: UK£0.052 loss per share (vs UK£0.30 loss in 1H 2022)

Now 21% undervalued

IP Group Plc to Report First Half, 2023 Results on Aug 02, 2023

Full year 2022 earnings released: UK£0.33 loss per share (vs UK£0.42 profit in FY 2021)

IP Group Plc to Report Fiscal Year 2022 Results on Mar 08, 2023

Scaleworks Inc. acquired Import.io Ltd.

IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director

Now 21% undervalued

Insufficient new directors

Insufficient new directors

Ip Group plc Announces the Initiation of Its Phase 2B Trial of Mbs2320, Its Lead Drug in Rheumatoid Arthritis, with the First Patients Now Dosed

First half 2022 earnings released

IP Group Plc Declares an Interim Dividend in Respect of the Period from 1 January 2022 to 30 June 2022, Payable on or Around 19 September 2022

IP Group Plc to Report First Half, 2022 Results on Aug 03, 2022

IP Group Plc Launches 'Kiko Ventures' Platform to Deepen Its Support for Transformative Climate Technology

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

IP Group Plc to Report Fiscal Year 2021 Results on Mar 16, 2022

Insider recently bought UK£61k worth of stock

Executive Officer recently bought UK£50k worth of stock

Investor sentiment improved over the past week

First half 2021 earnings released: EPS UK£0.11 (vs UK£0.011 in 1H 2020)

NeoGenomics Laboratories, Inc. completed the acquisition of remaining 88.95% stake in Inivata Limited from a group of sellers.

IP Group Plc Announces Inaugural Dividend, Payable on 16 June 2021

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Athenex, Inc. (NasdaqGS:ATNX) acquired Kuur Therapeutics Limited.

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Revenue beats expectations

IP Group Plc, Annual General Meeting, Jun 09, 2021

IP Group Plc to Report Fiscal Year 2020 Results on Mar 10, 2021

Centessa Pharmaceuticals Limited acquired ApcinteX from Medicxi Ventures (UK) LLP, Touchstone Innovations Plc, Cambridge Enterprise Seed Funds and IP Group Plc (LSE:IPO).

New 90-day high: UK£1.11

New 90-day high: UK£0.98

New 90-day high: UK£0.91

Integumen Plc (AIM:SKIN) reached an agreement to acquire Modern Water plc (AIM:MWG) from a group of sellers for £21.3 million.

An unknown buyer acquired an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO).

Hitachi Rail Limited agreed to acquire Perpetuum Ltd.

IP Group Plc to Report First Half, 2020 Results on Aug 05, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin